DelveInsight has launched a new report on Cholangiocarcinoma Epidemiology
Cholangiocarcinoma (CCA) also known as Biliary Tract Cancer is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation. The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules (canals of Hering) to the ampulla of Vater, as well as at the peribiliary glands (intramural and extramural) and sometimes may affect gall bladder.
Request for free sample copy- https://www.delveinsight.com/sample-request/cholangiocarcinoma-cca-epidemiology-forecast
The Cholangiocarcinoma Epidemiology Report covers the overview, treatment practice and forecasted epidemiology of Cholangiocarcinoma Epidemiology from 2020 to 2030
Cholangiocarcinoma Epidemiology
As per the study conducted by N Patel et al., the overall incidence of Cholangiocarcinoma from 2001 to 2015 was 1.26 per 100,000 people per year in the US. Males account for higher incidence with 50.9% cases while 49.1% cases belong to females in that study. The incidence has been shown to increase in all subpopulations and specifically at a dramatic rate for ICCA and those with distant disease at the time of diagnosis.
Key facts of the Cholangiocarcinoma Epidemiology
Cholangiocarcinoma Epidemiology Segmentation
Cholangiocarcinoma Prevalent Population
As per DelveInsight assessments, the market size of Cholangiocarcinoma (CCA) in the 7MM was found to USD XX million in 2017, for the study period (2017-2030). Among 7MM, United States accounts for the highest market size of Cholangiocarcinoma (CCA) in comparison with EU5 and Japan.
Table of content
1. Key Insights
2. Executive Summary of Cholangiocarcinoma (CCA)
3. Cholangiocarcinoma (CCA): Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
What are the reasons to buy?
The Cholangiocarcinoma (CCA) Epidemiology report will allow the user to –
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/